The weight-loss drug boom has transformed Eli Lilly (LLY), the maker of Zepbound, into the largest healthcare company in the ...

American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic ...

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

However, in Polar Capital Global Healthcare trust, investors will find an extreme outlier – over the same period, the vehicle ...

Northcape Capital’s Wendy Herringer isn’t deterred by the 40 per cent crash in Novo Nordisk and is all in on a waste disposal ...

Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...

Biosimilars have also made inroads among generic suppliers. But development is lengthy and expensive. McKinsey estimates that ...

In November, Amneal received FDA approval for exenatide, its first generic injectable glucagon-like peptide-1 (GLP-1) agonist ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Long-term investments in top tech, health, and consumer staples for stability, growth, and reliable returns. Read what ...